Ajooni Biotech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Revenue | 25.70 | 19.84 | 21.62 |
Operating Expense | 24.70 | 17.99 | 20.71 |
Net Profit | 0.47 | 0.91 | 0.44 |
Net Profit Margin | 1.83 | 4.59 | 2.04 |
Earning Per Share | 0.03 | 0.10 | 0.25 |
EBIDTA | 0.99 | 1.86 | 0.92 |
Effective Tax Rate | 15 | 32.43 | 16.30 |
Particulars | Jun 2024 |
---|---|
Revenue | 25.70 |
Operating Expense | 24.70 |
Net Profit | 0.47 |
Net Profit Margin | 1.83 |
Earning Per Share | 0.03 |
EBIDTA | 0.99 |
Effective Tax Rate | 15.00 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Total Revenue Annual | 74.49 | 74.04 | 51.04 |
Operating Expenses Annual | 71.72 | 70.96 | 49.39 |
Operating Profit Annual | 3.06 | 3.11 | 1.67 |
Interest Annual | 0.48 | 0.54 | 0.58 |
Depreciation | 1.00 | 0.97 | 0.44 |
Net Profit Annual | 1.12 | 1.05 | 0.37 |
Tax Annual | 0.45 | 0.41 | 0.13 |
Particulars | Mar 2023 |
---|---|
Total Revenue Annual | 74.49 |
Operating Expenses Annual | 71.72 |
Operating Profit Annual | 3.06 |
Interest Annual | 0.48 |
Depreciation | 1.00 |
Net Profit Annual | 1.12 |
Tax Annual | 0.45 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Cash Flow at the Beginning | 0.06 | 0.24 | 0.12 |
Cash Flow from Operations | -5.58 | 3.68 | 1.16 |
Cash Flow from Investing | -15.82 | -1.90 | -3.41 |
Cash Flow from Financing | 21.66 | -1.97 | 2.37 |
Cash Flow at the End | 0.31 | 0.06 | 0.24 |
Particulars | Mar 2023 |
---|---|
Cash Flow at the Beginning | 0.06 |
Cash Flow from Operations | -5.58 |
Cash Flow from Investing | -15.82 |
Cash Flow from Financing | 21.66 |
Cash Flow at the End | 0.31 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
PBDIT Margin (%) | 4.11 | 4.20 | 3.25 |
PBIT Margin (%) | 2.77 | 2.70 | 2.12 |
PBT Margin (%) | -2.96 | -2.30 | -1.52 |
Net PROFIT Margin (%) | 1.50 | 1.42 | 0.72 |
Return On Networth / Equity (%) | 3.86 | 6.55 | 2.34 |
Return On Networth /Employed (%) | 5.97 | 9.05 | 4.98 |
Return On Assets (%) | 3.26 | 4.75 | 1.70 |
Total Debt / Equity (X) | 0.18 | 0.38 | 0.37 |
Asset Turnover Ratio (%) | 2.17 | 3.35 | 2.35 |
Particulars | Mar 2023 |
---|---|
PBDIT Margin (%) | 4.11 |
PBIT Margin (%) | 2.77 |
PBT Margin (%) | -2.96 |
Net PROFIT Margin (%) | 1.50 |
Return On Networth / Equity (%) | 3.86 |
Return On Networth /Employed (%) | 5.97 |
Return On Assets (%) | 3.26 |
Total Debt / Equity (X) | 0.18 |
Asset Turnover Ratio (%) | 2.17 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|
Fixed Assets Annual | 6.29 | 6.21 | 5.16 |
Total Current Assets Annual | 34.67 | 21.93 | 21.43 |
Non Current Assets Annual | 24.06 | 7.09 | 6.60 |
Total Shareholders Funds Annual | 41.67 | 16.38 | 15.65 |
Total Assets Annual | 58.73 | 29.02 | 28.03 |
Particulars | Mar 2023 |
---|---|
Fixed Assets Annual | 6.29 |
Total Current Assets Annual | 34.67 |
Non Current Assets Annual | 24.06 |
Total Shareholders Funds Annual | 41.67 |
Total Assets Annual | 58.73 |
No Data Availabe